ICICI Securities has add call on Strides Pharma Science with a target price of Rs 939. The current market price of is Rs 849.3.
Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 7515.26 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 845.22 Crore, up 4.81 % from last quarter Total Income of Rs 806.43 Crore and up 13.50 % from last year same quarter Total Income of Rs 744.66 Crore. Company reported net profit after tax of Rs 62.07 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 29.7 per cent stake in the company as of June 30, 2020, while FIIs held 26.8 per cent, DIIs 19.4 per cent and public and others 24.1 per cent.
